Clinical Report: Physeal Disruption as an Indicator of Lung Metastasis
Overview
This study identifies physeal breach as a significant predictor of pulmonary metastasis in pediatric osteosarcoma patients. The findings suggest that physeal disruption may serve as a practical biomarker for risk stratification and treatment planning.
Background
Osteosarcoma is the most prevalent primary malignant bone tumor in adolescents, with pulmonary metastasis being the leading cause of mortality. Understanding the factors that contribute to metastatic spread is crucial for improving patient outcomes, especially since survival rates drop significantly once metastases are present. This study explores the relationship between physeal breach and lung metastasis, aiming to enhance risk assessment in pediatric osteosarcoma.
Data Highlights
Outcome
Percentage
Pulmonary metastases at diagnosis
22%
Pulmonary metastases by last follow-up
50%
Odds ratio for physeal breach predicting metastasis
59.89
Key Findings
Physeal breach was the only independent predictor of pulmonary metastasis (odds ratio 59.89).
22% of patients had pulmonary metastases at diagnosis, increasing to 50% by last follow-up.
All mice with physeal breach developed pulmonary metastases in the xenograft model.
VEGF immunohistochemistry indicated increased angiogenic activity in breach-associated tumors.
Routine imaging can readily identify breach status, aiding in risk stratification.
Clinical Implications
The identification of physeal breach as a predictor of metastasis emphasizes the need for careful imaging evaluation in pediatric osteosarcoma patients. Clinicians should consider breach status when developing treatment plans and risk stratification strategies for these patients.
Conclusion
Physeal breach serves as a significant indicator of metastatic potential in pediatric osteosarcoma, highlighting its utility in clinical practice for risk assessment and treatment planning.
